STipe Therapeutics Competitors and Similar CompaniesClear all
STipe Therapeutics's competitors and similar companies include MaxiVAX, Verseau Therapeutics, Metabolomic Technologies and Curis.
 STipe Therapeutics STipe Therapeutics is a biotechnology company that specializes in the immune-oncology field and therapies of interferon genes to target cancer. |  MaxiVAX MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. |  Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. |  Metabolomic Technologies Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
|  Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. | |
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 2017 | Founding Date 2010 | Founding Date 2000 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Aarhus, DK HQ | Locations Genève, CH HQ Genève, CH | Locations Bedford, US HQ | Locations Edmonton, CA HQ Edmonton, CA | Locations Lexington, US HQ Lexington, US |
Employees | Employees 205% decrease | Employees 5 | Employees 6 | Employees 3 | Employees 3144% decrease |
Financial | |||||
Net income | Net income (€8.3m) (FY, 2022) | Net income N/A | Net income N/A | Net income N/A | Net income ($7.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 21.9m (almost 7 years ago) | Latest funding round $ 5m (over 6 years ago) | Latest funding round $ 50m (over 6 years ago) | Latest funding round $ 4.2m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 21.9m | Total funding raised $ 8.1m | Total funding raised $ 50m | Total funding raised $ 4.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MaxiVAX
HQ
Genève, CH
Employees
5
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.
View companyVerseau Therapeutics
HQ
Bedford, US
Employees
6
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
View companyMetabolomic Technologies
HQ
Edmonton, CA
Employees
3
Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
View companyCuris
HQ
Lexington, US
Employees
31↓ 44% decrease
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
View company